Histrelin implant and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Histrelin implant and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: histrelin
Brand name: Supprelin LA, Vantas, Supprelin
Synonyms: Histrelin (implant), Histrelin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Histrelin implant-Moxifloxacin
- Histrelin implant-Moxifloxacin (Systemic)
- Histrelin implant-Moxifloxacin Hydrochloride
- Histrelin implant-Moxifloxacin Injection
- Histrelin implant-Moxifloxacin Intravenous
- Histrelin implant-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Histrelin Implant (CPP)
- Moxetumomab pasudotox-tdfk Intravenous-Histrelin Implant (Prostate Cancer)
- Moxetumomab pasudotox-tdfk Intravenous-Histrelin Subcutaneous
- Moxetumomab pasudotox-tdfk Intravenous-Histuss PD
- Moxetumomab pasudotox-tdfk Intravenous-Hivid
- Moxetumomab pasudotox-tdfk Intravenous-Hizentra